What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Visual acuity
- Ophthalmology
Frederick L. Ferris focuses on Ophthalmology, Visual acuity, Macular degeneration, Surgery and Diabetic retinopathy.
His research integrates issues of Risk factor and Diabetic macular edema in his study of Ophthalmology.
He interconnects Optometry, Ranibizumab and Confidence interval in the investigation of issues within Visual acuity.
The concepts of his Macular degeneration study are interwoven with issues in Framingham Risk Score, Fundus and Age related.
His study looks at the relationship between Surgery and topics such as Internal medicine, which overlap with Placebo.
His Diabetic retinopathy research is multidisciplinary, relying on both Retinopathy, Vitrectomy, Macular edema and Cytokine.
His most cited work include:
- Complement Factor H Polymorphism in Age-Related Macular Degeneration (3656 citations)
- Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales (1794 citations)
- New Visual Acuity Charts for Clinical Research (1726 citations)
What are the main themes of his work throughout his whole career to date?
Frederick L. Ferris mostly deals with Ophthalmology, Macular degeneration, Visual acuity, Diabetic retinopathy and Surgery.
His Ophthalmology research focuses on subjects like Prospective cohort study, which are linked to Atrophy.
His biological study spans a wide range of topics, including Fundus, Age related and Hazard ratio.
His Visual acuity research includes elements of Optometry, Ranibizumab and Randomized controlled trial.
While the research belongs to areas of Diabetic retinopathy, Frederick L. Ferris spends his time largely on the problem of Retinopathy, intersecting his research to questions surrounding Complication.
His Surgery research is multidisciplinary, incorporating elements of Internal medicine and Clinical trial.
He most often published in these fields:
- Ophthalmology (55.20%)
- Macular degeneration (34.05%)
- Visual acuity (31.18%)
What were the highlights of his more recent work (between 2013-2021)?
- Ophthalmology (55.20%)
- Macular degeneration (34.05%)
- Visual acuity (31.18%)
In recent papers he was focusing on the following fields of study:
Frederick L. Ferris spends much of his time researching Ophthalmology, Macular degeneration, Visual acuity, Ranibizumab and Surgery.
Ophthalmology connects with themes related to Diabetic retinopathy in his study.
The study incorporates disciplines such as Clinical research and MEDLINE in addition to Diabetic retinopathy.
His studies deal with areas such as Prospective cohort study and Age related as well as Macular degeneration.
His Visual acuity research integrates issues from Adverse effect, Randomized controlled trial and Clinical trial.
His Ranibizumab study combines topics in areas such as Regimen, Crossover study and Randomization.
Between 2013 and 2021, his most popular works were:
- Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. (794 citations)
- Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial. (385 citations)
- Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial. (351 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Visual acuity
- Disease
Frederick L. Ferris mainly investigates Ophthalmology, Visual acuity, Macular degeneration, Ranibizumab and Surgery.
His Ophthalmology study combines topics from a wide range of disciplines, such as Prospective cohort study and Randomized controlled trial.
His studies in Visual acuity integrate themes in fields like Adverse effect, Clinical trial, Nuclear medicine and Optical coherence tomography.
His Macular degeneration research incorporates themes from Eye disease and Internal medicine, Age related.
His work carried out in the field of Ranibizumab brings together such families of science as Diabetic retinopathy and Regimen.
His Surgery research is multidisciplinary, incorporating perspectives in Photocoagulation therapy and Case-control study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
